Neovasc Inc. EBIT

EBIT of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including EBIT growth rates and interactive chart. Earnings before interest and taxes is an indicator of a company's profitability. One can calculate it as revenue minus all expenses, excluding tax and interest. EBIT is also referred to as operating earnings, operating profit, and profit before interest and taxes. It is the amount of profit that a company earns before interest on debt and taxes are paid.


Highlights and Quick Summary

  • EBIT for the quarter ending March 31, 2022 was $-6.62 Million (a 29.26% increase compared to previous quarter)
  • Year-over-year quarterly EBIT decreased by -27.22%
  • Annual EBIT for 2021 was $-58 Million (a -21.27% decrease from previous year)
  • Annual EBIT for 2020 was $-73.7 Million (a 20.56% increase from previous year)
  • Annual EBIT for 2019 was $-61.1 Million (a 88.58% increase from previous year)
  • Twelve month EBIT ending March 31, 2022 was $-27.6 Million (a -11.43% decrease compared to previous quarter)
  • Twelve month trailing EBIT decreased by -28.65% year-over-year
Trailing EBIT for the last four month:
31 Mar '22 31 Dec '21 30 Sep '21 30 Jun '21
$-27.6 Million $-31.1 Million $-35.2 Million $-38.6 Million
Visit stockrow.com/NVCN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EBIT of Neovasc Inc.

Most recent EBITof NVCN including historical data for past 10 years.

Interactive Chart of EBIT of Neovasc Inc.

Neovasc Inc. EBIT for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $-6.62
2021 $-5.12 $-6.72 $-9.09 $-10.17 $-58.01
2020 $-9.19 $-10.17 $-8.66 $-7.16 $-73.68
2019 $-9.57 $-6.99 $-6.63 $-6.85 $-61.12
2018 $-10.25 $-9.65 $-6.0 $-6.5 $-32.41
2017 $-12.21 $-5.83 $-6.3 $-7.82 $-61.76
2016 $-6.73 $-7.59 $-12.99 $-9.51 $-36.82
2015 $-8.06 $-8.67 $-6.83 $-5.18 $-28.76
2014 $-7.09 $-4.38 $-5.91 $-0.37 $-17.27
2013 $-2.23 $-1.34 $-1.36 $-1.94 $-6.9
2012 $-1.0 $-1.2 $-1.49 $-1.24 $-4.92
2011 $1.8 $-3.88

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.